Skip to main content
Premium Trial:

Request an Annual Quote

Randall Durnell, Kavita Reddy, Carl Hull, Kevin Cooksy, Julie Brooks, Brenda Rogers

Randall Durnell has been named vice president of commercial operations at GenTel Biosciences, the firm said this week.
Durnell previously held positions at Beckman Coulter, Aurora Biosciences, and Pierce Biotechnology.

CombiMatrix Molecular Diagnostics has hired Kavita Reddy to be its laboratory director. Reddy formerly was senior director of Genzyme Genetics Manhattan, and she was an associate director and scientific director of Quest Diagnostics.

Gen-Probe Chief Operating Officer Carl Hull will take on the additional title of president in March. Hull joined the company a year ago as executive vice president and COO. Hull formerly was VP and general manager of Applied Biosystems’ sequence detection system and microarrays business, and he previously was involved in sales and marketing at Ventana Medical Systems and at Abbott Laboratories.

Perlegen announced three new hires last week, naming Kevin Cooksy to be vice president of business development; Julie Brooks general counsel and corporate secretary; and Brenda Rogers to be VP of human resources.
Cooksy previously was involved in corporate development at Agilent Technologies; Brooks served in a variety of legal and corporate management positions at healthcare technology companies, including Westmark International and Access Health; and Rogers was a consultant to biotech companies and was VP of human resources at OneWorld Health.

The Scan

Follow-Up Data Requests to Biobank Participants Ineffective, Study Finds

An effort to recontact biobank enrollees for additional information reports low participation in a new BMJ Open study.

Study Finds Widespread Transmission of Resistant Bacteria in Vietnam Hospitals

A sequencing study in The Lancet Microbe finds widespread transmission of drug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two Vietnam ICUs.

Novel Brain Cell Organoids Show Promise for Autism Research

University of Utah researchers report in Nature Communications on their development of brain cell organoids to study SHANK3-related autism.

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.